03/10/2024 - Abivax SA: Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease

The text version of this document is not available. You can access the original document here.

Disclaimer

Abivax SA published this content on October 03, 2024 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on October 03, 2024 at 20:29:41 UTC.